{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:45:45Z","timestamp":1791600345994,"version":"4.3.4"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.3816\/cbc.2009.n.005","type":"journal-article","created":{"date-parts":[[2009,3,19]],"date-time":"2009-03-19T21:12:05Z","timestamp":1237497125000},"page":"29-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":378,"title":["Survival Outcomes for Patients with Metastatic Triple-Negative Breast Cancer: Implications for Clinical Practice and Trial Design"],"prefix":"10.3816","volume":"9","author":[{"given":"Farrah","family":"Kassam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Enright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Dent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Dranitsaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candi","family":"Flynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Fralick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritu","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Clemons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.3816\/CBC.2009.n.005_bib1","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.1073\/pnas.191367098","article-title":"Gene expression patterns of breast carcinomas distinguish tumour subclasses with clinical implications","volume":"98","author":"Sorlie","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3816\/CBC.2009.n.005_bib2","doi-asserted-by":"crossref","first-page":"8418","DOI":"10.1073\/pnas.0932692100","article-title":"Repeated observation of breast tumour subtypes in independent gene expression data sets","volume":"100","author":"Sorlie","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3816\/CBC.2009.n.005_bib3","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"Perou","year":"2000","journal-title":"Nature"},{"key":"10.3816\/CBC.2009.n.005_bib4","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/modpathol.3800528","article-title":"Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma","volume":"19","author":"Livasy","year":"2006","journal-title":"Mod Pathol"},{"key":"10.3816\/CBC.2009.n.005_bib5","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1136\/jcp.2005.033043","article-title":"Basal-like breast carcinomas: clinical outcome and response to chemotherapy","volume":"59","author":"Banerjee","year":"2006","journal-title":"J Clin Pathol"},{"key":"10.3816\/CBC.2009.n.005_bib6","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/cncr.22618","article-title":"Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple negative phenotype","volume":"109","author":"Bauer","year":"2007","journal-title":"Cancer"},{"key":"10.3816\/CBC.2009.n.005_bib7","doi-asserted-by":"crossref","first-page":"5652","DOI":"10.1200\/JCO.2006.06.5664","article-title":"Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer","volume":"24","author":"Haffty","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.3816\/CBC.2009.n.005_bib8","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1158\/1078-0432.CCR-06-3045","article-title":"Triple negative breast cancer: clinical features and patterns of recurrence","volume":"13","author":"Dent","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.3816\/CBC.2009.n.005_bib9","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1001\/jama.295.21.2492","article-title":"Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study","volume":"295","author":"Carey","year":"2006","journal-title":"JAMA"},{"key":"10.3816\/CBC.2009.n.005_bib10","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1158\/1078-0432.CCR-05-2281","article-title":"Prognostic significance of basallike phenotype and fascin expression in node-negative invasive breast carcinomas","volume":"12","author":"Rodriguez-Pinilla","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.3816\/CBC.2009.n.005_bib11","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumours","volume":"92","author":"Therasse","year":"2000","journal-title":"JNCI"},{"key":"10.3816\/CBC.2009.n.005_bib12","article-title":"Patterns of metastatic spread in triple negative breast cancer","author":"Dent","year":"2008","journal-title":"Breast Cancer Res Treat"},{"key":"10.3816\/CBC.2009.n.005_bib13","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/01.coc.0000258125.97090.3f","article-title":"Survival differences observed in metastatic breast cancer patients treated with capecitabine when compared with vinorelbine after pretreatment with anthracycline and taxane","volume":"30","author":"Verma","year":"2007","journal-title":"Am J Clin Oncol"},{"key":"10.3816\/CBC.2009.n.005_bib14","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/cncr.11083","article-title":"Survival of patients with metastatic breast carcinoma","volume":"97","author":"Chang","year":"2003","journal-title":"Cancer"},{"key":"10.3816\/CBC.2009.n.005_bib15","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1159\/000227037","article-title":"Development and validation of prognositic models in metastatic breast cancer: a GOCS study","volume":"49","author":"Rabinovich","year":"1992","journal-title":"Oncology"},{"key":"10.3816\/CBC.2009.n.005_bib16","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1002\/1097-0142(19801201)46:11<2380::AID-CNCR2820461113>3.0.CO;2-M","article-title":"Prediction of outcome in metastatic breast cancer treated with adriamycin combination chemotherapy","volume":"46","author":"Nash","year":"1980","journal-title":"Cancer"},{"key":"10.3816\/CBC.2009.n.005_bib17","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.breast.2005.03.001","article-title":"Prediction of survival from first recurrence of breast carcinoma in Japanese women","volume":"15","author":"Takeuchi","year":"2006","journal-title":"The Breast"},{"key":"10.3816\/CBC.2009.n.005_bib18","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1023\/A:1006285726561","article-title":"Prognostic factors predicting survival from first recurrence in patients with metastatic breast cancer: analysis of 439 patients","volume":"56","author":"Insa","year":"1999","journal-title":"Breast Cancer Res Treat"},{"key":"10.3816\/CBC.2009.n.005_bib19","first-page":"462","article-title":"Identification and assessment of prognostic factors","volume":"15","author":"George","year":"1988","journal-title":"Semin Oncol"},{"key":"10.3816\/CBC.2009.n.005_bib21","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1200\/JCO.1983.1.12.776","article-title":"Multivariate analysis of prognostic factors in metastatic breast cancer","volume":"1","author":"Hortobagyi","year":"1983","journal-title":"J Clin Oncol"},{"key":"10.3816\/CBC.2009.n.005_bib22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1200\/JCO.1987.5.1.55","article-title":"Survival from first recurrence: relative importance of prognostic factors in 1, 015 breast cancer patients","volume":"5","author":"Clark","year":"1987","journal-title":"J Clin Oncol"},{"key":"10.3816\/CBC.2009.n.005_bib23","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/cncr.22381","article-title":"Prognostic markers in triple-negative breast cancer","volume":"109","author":"Rakha","year":"2007","journal-title":"Cancer"},{"key":"10.3816\/CBC.2009.n.005_bib24","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/1471-2407-7-134","article-title":"Use of immunohistochemical markers can refine prognosis in triple negative breast cancer","volume":"7","author":"Tischkowitz","year":"2007","journal-title":"BMC Cancer"},{"key":"10.3816\/CBC.2009.n.005_bib25","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1158\/1078-0432.CCR-07-1658","article-title":"Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype","volume":"14","author":"Cheang","year":"2008","journal-title":"Clin Cancer Res"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820911706395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820911706395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:09:32Z","timestamp":1761512972000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820911706395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S1526820911706395"],"URL":"https:\/\/doi.org\/10.3816\/cbc.2009.n.005","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Survival Outcomes for Patients with Metastatic Triple-Negative Breast Cancer: Implications for Clinical Practice and Trial Design","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.3816\/CBC.2009.n.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}